MBX shares are currently trading at $28.67, with analysts maintaining a Strong Buy consensus and a high target of $80, according to InvestingPro data. The price target increase comes after MBX’s ...
Fintel reports that on December 19, 2025, Stifel maintained coverage of MBX Biosciences (NasdaqGS:MBX) with a Buy recommendation. Analyst Price Forecast Suggests 108.57% Upside As of December 6, 2025, ...
MBX Biosciences Inc. (NASDAQ:MBX) is one of the stocks that will double in 2026. On December 4, Goldman Sachs initiated coverage of MBX Biosciences with a Sell rating and $18 price target. The key ...
In recent months, MBX Biosciences reported positive topline Phase 2 results for its lead drug canvuparatide in hypoparathyroidism and completed an upsized US$200,000,000 capital raise, while ...
Regular visitors to TopGear.com will know that Skoda has recently been digging into its back catalogue to reimagine classics using its current ‘Modern Solid’ design language – see the 110 R – and the ...
Investing.com - Oppenheimer has reiterated an Outperform rating and $80.00 price target on MBX Biosciences Inc (NASDAQ:MBX), despite the stock falling 30% since its Phase 2 data announcement.
The city of Wausau has acquired the former MBX Packaging Specialists site on the west side riverfront. The $900,000 purchase was approved by the Common Council and aided by a $250,000 foundation grant ...
MBX Biosciences (NASDAQ:MBX) has priced its public offering of 11,108,055 shares at $18.00 per share. The upsized offering is expected to generate gross proceeds of approximately $199.9 million for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback